Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 5 (12), e15367

Tissue Distribution of 5-hydroxymethylcytosine and Search for Active Demethylation Intermediates

Affiliations

Tissue Distribution of 5-hydroxymethylcytosine and Search for Active Demethylation Intermediates

Daniel Globisch et al. PLoS One.

Abstract

5-Hydroxymethylcytosine (hmC) was recently detected as the sixth base in mammalian tissue at so far controversial levels. The function of the modified base is currently unknown, but it is certain that the base is generated from 5-methylcytosine (mC). This fuels the hypothesis that it represents an intermediate of an active demethylation process, which could involve further oxidation of the hydroxymethyl group to a formyl or carboxyl group followed by either deformylation or decarboxylation. Here, we use an ultra-sensitive and accurate isotope based LC-MS method to precisely determine the levels of hmC in various mouse tissues and we searched for 5-formylcytosine (fC), 5-carboxylcytosine (caC), and 5-hydroxymethyluracil (hmU) as putative active demethylation intermediates. Our data suggest that an active oxidative mC demethylation pathway is unlikely to occur. Additionally, we show using HPLC-MS analysis and immunohistochemistry that hmC is present in all tissues and cell types with highest concentrations in neuronal cells of the CNS.

Conflict of interest statement

Competing Interests: Funding was received from Bayer-Schering Pharma AG, which does not alter the authors' adherence to the policies of PLoS ONE.

Figures

Figure 1
Figure 1. Putative demethylation pathways.
Depiction of the known cytosine modifications mC and hmC and of the putative oxidative “demethylation” intermediates fC and caC. The base excision repair (BER) pathway is a second possible demethylation pathway via the intermediate hmU.
Figure 2
Figure 2. Synthesis of [D2]-hmC and the putative intermediates fC, caC, and hmU.
a) CO, PPh3, Pd2(dba)3·CHCl3, Bu3SnH, 97%, with Bu3SnD 49%, b) HF pyridine, 75%, c) NaBD4, CeCl3·7H2O, 21%, d) TBAF, 51%, e) CO, TMS-Et-OH, DIPEA, Pd2Cl2(MeCN)2, 52%, f) TBAF, 69%, g) Reference h) HF·pyridine, 70%. All reactions could also be carried out in a protective group free manner but resulted in reduced yields and tedious workups (see Figure S2 for details).
Figure 3
Figure 3. Workflow of the HPLC-MS quantification method.
DNA is extracted from any kind of tissue and subsequently enzymatically digested to the nucleosides. Subsequently, a known amount of the stable isotope-labeled standard nucleoside is added. In the HPLC-MS analysis one signal for the natural (light) and one for the synthetic (heavy) compound is detected in each experiment. Quantification is performed by comparing the integrals of the specific high resolution ion current of the natural compound (amount to be determined) with their corresponding heavy atom labeled derivative (known amount).
Figure 4
Figure 4. Quantification of hmC and mC in mouse tissue.
A) Values of hmC in % of dG. B) Values of mC in % of dG. A)+B) Data represent values for each tissue of at least two mice with standard deviation (SD) (See Table S1 for details). Light-colored bars represent data from our earlier study .
Figure 5
Figure 5. Immunolocalization of hmC in mouse hippocampus, kidney, and liver.
Scale bar: 200 µM. Left column: mouse tissues stained with anti-hmC (green). Middle column: mouse tissues stained with anti-hmC (green) and Hoechst 33342 (blue) for nuclear staining. Right column: Bright field pictures of corresponding tissue. In every second row 2 µM hmC-DNA were added to compete the anti-hmC staining signal out.
Figure 6
Figure 6. Immunolocalization of hmC in mouse hippocampus.
High magnification images of hmC immunoreactivity in the dentate gyrus (DG) and the hilus of mouse hippocampus. A) Signal for anti-hmC (green) and Hoechst 33342 nuclear dye (blue) B) Competition of anti-hmC with 2 µM hmC-DNA. The scale bar marks 20 µm.
Figure 7
Figure 7. Detection of potential demethylation intermediates caC, hmU, and fC.
A) HPLC-chromatogram of the synthesized cytosine and uracil modifications caC, hmC, hmU, mC, and fC as 2′-deoxynucleosides showing excellent separation of the compounds. B) Detected values of the potential intermediates as example in olfactory bulb. The red line indicates the detection limits of the modified nucleosides in enzymatically digested DNA samples.

Similar articles

See all similar articles

Cited by 312 PubMed Central articles

See all "Cited by" articles

References

    1. Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in purkinje neurons and the brain. Science. 2009;324:929–930. - PMC - PubMed
    1. Tahiliani M, Koh KP, Shen YH, Pastor WA, Bandukwala H, et al. Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. Science. 2009;324:930–935. - PMC - PubMed
    1. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010;11:204–220. - PMC - PubMed
    1. Liutkeviciute Z, Lukinavicius G, Masevicius V, Daujotyte D, Klimasauskas S. Cytosine-5-methyltransferases add aldehydes to DNA. Nat Chem Biol. 2009;5:400–402. - PubMed
    1. Miller CA, Sweatt JD. Covalent modification of DNA regulates memory formation. Neuron. 2007;53:857–869. - PubMed

Publication types

LinkOut - more resources

Feedback